bromodeoxyuridine has been researched along with ptc-209 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arrowsmith, CH; Baiazitov, R; Cao, L; Davis, T; Dick, JE; Du, W; Frelin, C; Gallinger, S; Gibson, L; Iscove, NN; Kreso, A; Leung, C; Lima-Fernandes, E; Moon, YC; O'Brien, CA; Pedley, NM; Sydorenko, N; Szentgyorgyi, E; van Galen, P; Wang, Y | 1 |
1 other study(ies) available for bromodeoxyuridine and ptc-209
Article | Year |
---|---|
Self-renewal as a therapeutic target in human colorectal cancer.
Topics: Animals; Blotting, Western; Bromodeoxyuridine; Cell Line, Tumor; Colorectal Neoplasms; Flow Cytometry; Genetic Vectors; Heterocyclic Compounds, 2-Ring; Humans; Luciferases; Mice, Inbred NOD; Mice, SCID; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Polycomb Repressive Complex 1; RNA Interference; RNA, Small Interfering; Thiazoles | 2014 |